Prescient Therapeutics (ASX:PTX) Share Price and News

Prescient Therapeutics Limited, a clinical stage oncology company, develops drugs for the treatment of various cancers in Australia. Its lead drug candidate is PTX-100, a first in class compound with the ability to block an cancer growth enzyme, thereby disrupting the oncogenic Ras pathway. The company was formerly known as Virax Holdings Limited and changed its name to Prescient Therapeutics Limited in December 2014. Prescient Therapeutics Limited was incorporated in 1986 and is based in Melbourne, Australia.

Expand Company Description

Market Cap (10-Oct) $37,044,720 (780th)	Close (30-Jun) $0.081 0 (0%)	Volume (30-Jun) 2,818,974	Shortsold (13-Feb) 21,991 (0.00%) (605th)
52w High $0.105	52w Low $0.037	P/E -	EPS -0.01
ASX Announcements (7d) -	Twitter Mentions (7d) 0+	AFR Articles (7d) -	News Articles (7d) 1+

	Subject
	PTX PTX Ann: Application for quotation of securities - PTX
	1 (current) 2 3
	PTX PTX Ann: Two PTX abstracts accepted at prestigious ISCT conference
	PTX PTX Ann: Initial Director's Interest Notice
	PTX PTX Ann: Notification regarding unquoted securities - PTX
	PTX PTX Ann: Experienced Pharma Executive Joins Prescient Board
	PTX PTX Ann: Notification of cessation of securities - PTX
	PTX PTX Ann: Change of Director's Interest Notices x3
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: Section 708A Cleansing Notice
	PTX PTX Ann: March 2023 Quarterly Update and Appendix 4C
	PTX PTX Ann: Change of Director's Interest Notices x2
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: Exercise and Expiry of Listed Options
	PTX PTX Ann: Continued promising results in PTX-100 TCL trial
	PTX PTX Ann: FDA grants broader orphan drug status to PTX100 for TCLs
	PTX PTX Ann: Revised Securities Trading Policy
	PTX PTX Ann: Appendix 4D and Half Year Financial Report
	PTX PTX Ann: Notification of Expiry of Listed Options
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: December 2022 Quarterly Update and Appendix 4C
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: Change of Director's Interest Notice
	PTX PTX Ann: Notification of cessation of securities - PTX
	PTX PTX Ann: Section 708A Cleansing Notice
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: Results of Annual General Meeting
	PTX PTX Ann: AGM Presentation
	PTX PTX Ann: Chair's Address to the 2022 Annual General Meeting
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: PTX Investor presentation and additional patient response
	PTX PTX Ann: September 2022 Quarterly Update and Appendix 4C
	PTX PTX Ann: Notice of Annual General Meeting/Proxy Form
	PTX PTX Ann: PTX-100 Trial Update
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: Section 708A Cleansing Notice
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: Change of Director's Interest Notices x2
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: Proposed issue of securities - PTX
	PTX PTX Ann: Placement Results
	PTX PTX Ann: SPP Results and Placement
	PTX PTX Ann: Trading Halt
	PTX PTX Ann: Extension of Share Purchase Plan
	PTX PTX Ann: CellPryme-A Investor Presentation
	PTX PTX Ann: PTX unveils CellPryme-A to boost CAR-T performance
	PTX PTX Ann: Prescient unveiling CellPryme-A at CAR-TCR summit in Boston
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: PTX strategic collaboration with MD Anderson Cancer Center

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
10-Oct	$0.05	515,110	+0.00 (8.70%)
09-Oct	$0.05	137,859	0.00 (2.13%)
08-Oct	$0.05	448,405	0.00 (0.00%)
07-Oct	$0.05	677,428	+0.00 (4.44%)
04-Oct	$0.05	810,467	0.00 (0.00%)
03-Oct	$0.05	2,124,129	+0.00 (12.50%)
02-Oct	$0.04	219,063	+0.00 (2.56%)
01-Oct	$0.04	866,308	0.00 (4.88%)
30-Sep	$0.04	606,074	0.00 (4.65%)
11-Sep	$0.04	283,249	0.00 (2.27%)
10-Sep	$0.04	1,138,687	0.00 (6.38%)
09-Sep	$0.05	283,029	+0.00 (4.44%)
06-Sep	$0.05	576,519	0.00 (2.17%)
05-Sep	$0.05	1,856,544	+0.00 (9.52%)
04-Sep	$0.04	639,781	0.00 (4.55%)
6 up, 7 down, and 2 flat days

High $0.09	Low $0.08	Trades 83	Turnover $220,412	Volume 2,818,974
30 June 2023 at 4:10pm

High $0.09	Low $0.08	Trades 83	Turnover $220,412	Volume 2,818,974
30 June 2023 at 4:10pm

Prescient Therapeutics Health Care
Cancer Therapeutics

$0.081 0.002 (2.53%)

$0.081 0.002 (2.53%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Prescient Therapeutics Health Care Cancer Therapeutics

$0.081 0.002 (2.53%)

$0.081 0.002 (2.53%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Prescient Therapeutics Health Care
Cancer Therapeutics